CVI Holdings, LLC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q111. A total of 15 filers reported holding HUMACYTE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CVI Holdings, LLC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$40,478
-17.7%
56,416
-25.3%
0.08%
+53.8%
Q2 2023$49,161
-50.0%
75,528
-53.9%
0.05%
+40.5%
Q1 2023$98,263
+25.9%
163,772
-17.6%
0.04%
+270.0%
Q4 2022$78,054
-69.6%
198,812
-15.0%
0.01%
-50.0%
Q3 2022$257,000
+17.9%
233,930
-4.5%
0.02%
+25.0%
Q2 2022$218,000
-57.8%
244,825
-9.0%
0.02%
-52.9%
Q1 2022$517,000
-22.3%
269,138
-7.8%
0.03%
-22.7%
Q4 2021$665,000
+22.2%
291,832
+58.7%
0.04%
+29.4%
Q3 2021$544,000183,8500.03%
Other shareholders
HUMACYTE INC shareholders Q1 2022
NameSharesValueWeighting ↓
RPO LLC 81,705$159,0000.05%
CVI Holdings, LLC 269,138$517,0000.03%
Sio Capital Management, LLC 49,998$97,0000.03%
Alpine Global Management, LLC 95,000$182,0000.02%
Exos Asset Management LLC 27,151$53,0000.02%
TUDOR INVESTMENT CORP ET AL 236,549$461,0000.01%
LMR Partners LLP 50,000$353,0000.00%
P SCHOENFELD ASSET MANAGEMENT LP 19,155$37,0000.00%
Diameter Capital Partners LP 19,085$37,0000.00%
HRT FINANCIAL LP 50,250$96,0000.00%
View complete list of HUMACYTE INC shareholders